Creative Biolabs-Immuno-oncology

PharmaOnco™ Human Molm13-Luc Tumor Cell Line (CAT#: IOC-02P004)

DatasheetDatasheet
Short Description
Luciferase-labeled human Molm13 cell
Description
Researchers at the Creative Biolabs have developed a Molm13-luciferase cell line that allows for intravital imaging to evaluate anti-cancer agents in acute monocytic leukemia. Furthermore, the Molm13-luciferase cell line is helpful in assessing the tumor- take to select mice for treatments groups based on equivalent tumor burden.
Applications
in vivo Imaging
Organism
Human
Disease
acute monocytic leukemia
Tested Data Related Products

COACOA

IOC-02P004-1 Fig.1 Cell morphology of PharmaOnco™ Human Molm13-Luc Tumor Cell Line (CAT#: IOC-02P004).

Cell Morphology

Cell morphology under the bright field.

IOC-02P004-3 Fig.3 Mycoplasma Testing of PharmaOnco™ Human Molm13-Luc Tumor Cell Line (CAT#: IOC-02P004).

Mycoplasma Testing

Mycoplasma contamination is detected by using a PCR Mycoplasma Test Kit. The kit utilizes the polymerase chain reaction (PCR), which was established as the method of choice for highest sensitivity in the detection of mycoplasma and acholeplasma contamination in cell cultures and other cell culture-derived biologicals.
The results showed that the cell line was negative for Mycoplasma.
Lane M: Marker;
Lane 1-2: Cell culture medium from MOLM13-LUC;
Lane 3: Negative control;
Lane 4: Positive control;

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving